| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 08/12/2009 | CN101502498A Curcumin preparation for percutaneous administration and preparation method thereof |
| 08/12/2009 | CN101502326A Method for preparing vitamin E nano liposome |
| 08/12/2009 | CN100525801C Application of plantain herb in preparing medicine and health article with lead removal promoting effect |
| 08/11/2009 | US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs |
| 08/11/2009 | CA2375378C Antilipemic combinations comprising hmg-coa reductase inhibitors and carnitines |
| 08/11/2009 | CA2236699C Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 08/06/2009 | WO2009096905A1 Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds |
| 08/06/2009 | WO2009096579A1 Nutritional composition for prevention of hyperglycemia |
| 08/06/2009 | WO2009095615A2 Use of an active agent derived from cyperus esculentus for the cutaneous anti-ageing action thereof |
| 08/05/2009 | EP2085087A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 08/05/2009 | CN101496856A Proanthocyanidin chewing tablet |
| 08/05/2009 | CN101496853A Qi-benefitting, yin-nourishing, blood circulation-promoting and apophlegmatic dropping pill and preparation method thereof |
| 08/05/2009 | CN101496796A Composite soft capsule of lycopene |
| 08/05/2009 | CN101496603A Health-care food with enhancing immunity and antioxidation functions |
| 08/05/2009 | CN100522193C Use of Broussonetia papyrifera red pigment |
| 08/05/2009 | CN100522186C Sustained release capsules of ginkgo leaf and preparation method |
| 08/05/2009 | CN100522185C Extractive of Abalone mushroom, extraction method and application thereof |
| 08/05/2009 | CN100522184C Extract with anti-tumor and anti-poisonous activity |
| 08/05/2009 | CN100522181C Anoxia and fatigue-resisting health-care oxygen, its preparation and use as health-care product |
| 07/30/2009 | WO2009092323A1 Uses of pdcd5 polypeptide for tumor chemotherapy and organ protection |
| 07/30/2009 | CA2704128A1 Novel composition for treating the side effects of anticancer treatments |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | CN100518806C Medicinal composition |
| 07/29/2009 | CN100518735C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/28/2009 | US7566698 Extracted from plants such as Ningxia Lycium barbarum L. and/or Lycium chinense Mill; glucosyltransferases, cellulases; provitamin C with improved stability and bioavailability; ultraviolet damage protector; antiwrinkling; whitening |
| 07/23/2009 | US20090186109 Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production |
| 07/22/2009 | EP1890692B1 Formulations of lipoic acid and the benzyl ester of hyaluronic acid in the pharmaceutical and cosmetic fields |
| 07/22/2009 | EP1453528B1 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 07/22/2009 | EP1244455B1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/16/2009 | WO2009087988A1 Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181105 Method of antioxidation, antioxidant-functioning water, and usage of the same |
| 07/16/2009 | DE102008004090A1 Biochemical or pharmaceutical mixture comprises co-enzyme Q10 (ubiquinone), where the co-enzyme Q10 are transported to the animal/human cells through cell membrane by isotonic saline solution (sodium chloride) and/or L-lysine, as carrier |
| 07/16/2009 | CA2711611A1 Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 07/15/2009 | CN100513571C Recombinant helicobacter pylori catalase |
| 07/15/2009 | CN100513560C Method for virus propagation |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/09/2009 | WO2009084743A1 External preparation for preventive or therapeutic use |
| 07/09/2009 | WO2009084612A1 Eriocitrin-containing material, method for production of the eriocitrin-containing material, and food, beverage, pharmaceutical preparation and cosmetic each comprising the eriocitrin-containing material |
| 07/09/2009 | WO2009084482A1 Composition comprising sesamin component and quercetin glycoside |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176735 Preventing or reducing oxidative stress or oxidative cell injury |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | CA2710379A1 Compositions containing sesamin-class compound(s) and quercetin glycoside(s) |
| 07/08/2009 | EP2077116A1 Use of interleukin-11 as therapeutic agent for heart disease |
| 07/08/2009 | EP2076290A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/07/2009 | US7557146 Method of preparing lycopene-enriched formulations that are free of organic solvents, formulations thus obtained, compositions comprising said formulations and use of same |
| 07/07/2009 | US7556824 Transdermal patch comprising hydralazine derivative antioxidant and isosorbide di- and/or mononitrate |
| 07/07/2009 | CA2368165C Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 07/02/2009 | WO2009043176A9 Herbal compositions and methods for treating hepatic disorders |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169630 Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications |
| 07/02/2009 | US20090169612 Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes |
| 07/01/2009 | EP2075276A1 Method for producing a sorbent based on a methyl- silicic acid hydrogel |
| 06/30/2009 | US7553837 Phenylazole compounds production process and antioxidants |
| 06/30/2009 | US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
| 06/25/2009 | WO2009078474A1 An agent for reducing a side effect of an anticancer drug |
| 06/25/2009 | WO2009078366A1 α-LIPOIC ACID NANOPARTICLE AND METHOD FOR PRODUCING THE SAME |
| 06/25/2009 | US20090163439 Methods of using beta glucan as a radioprotective agent |
| 06/25/2009 | US20090162427 Vaccines using nucleic acid-lipid complexes |
| 06/25/2009 | US20090162340 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 06/25/2009 | CA2707010A1 .alpha.-lipoic acid nanoparticles and methods for preparing thereof |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550285 Endotoxin binding lactic acid bacteria and bifidobacteria |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2373852C Oligosaccharide aldonic acids and their topical use |
| 06/23/2009 | CA2367387C Composition comprising isoquercetin and ascorbic acid in a sustained release form |
| 06/23/2009 | CA2304820C Stabilized bioactive preparations and methods of use |
| 06/18/2009 | WO2009075573A1 Paediatric fibre mixture |
| 06/18/2009 | WO2009075564A1 Paediatric fibre mixture |
| 06/18/2009 | US20090156689 Method of enhancing biological activity of plant extracts |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/17/2009 | EP2068893A2 Liquid chalcogenide compositions and methods of manufacturing and using the same |
| 06/17/2009 | EP1390378B1 Pharmaceutically active uridine esters |
| 06/17/2009 | CN100500147C New formulations and use thereof |
| 06/16/2009 | US7547728 (N-(4-nitro-3-trifluoromethyl)phenyl)-(2S)-3-(4- (acetylamino) phenoxy)-2-hydroxy-2-methylpropanamide) derivatives |
| 06/16/2009 | US7547527 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 06/16/2009 | CA2304975C Stabilized preparations for use in metered dose inhalers |
| 06/11/2009 | WO2009072004A2 Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor |
| 06/11/2009 | CA2701071A1 Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP0732924B1 Tts containing a parasympathomimetic and a parasympatholytic agent |
| 06/09/2009 | US7544653 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 06/09/2009 | CA2410706C Composition and applicator for topical substance delivery |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009068798A1 Compositions based on positively-charged cyclodextrins for preserving cells, tissues and organs, method for obtaining same and uses thereof |
| 06/04/2009 | WO2008101195A4 Drug resistance reversal in neoplastic disease |
| 06/03/2009 | EP2065045A1 Antioxidant for preventing and treating diseases caused by oxidative stress |
| 06/03/2009 | EP2063908A2 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 06/03/2009 | CN100495028C A process for the isolation of a major harmful oxidant from cigarette smoke |
| 06/03/2009 | CN100493501C Scopolamine hydrobromide dry powder inhalant for nose and preparing method |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | CA2371728C High dose radionuclide complexes for bone marrow suppression |